Some of the key players profiled in the mice model market report include
Charles River Laboratories International Inc
Taconic Biosciences, Inc.
Janvier Labs
genOway
Hera Biolabs
TransViragen Inc.
The Jackson Laboratory
Inotiv
Allentown LLC
Harbour Biomed
PolyGene
These firms engage in promising acquisitions and mergers to propel their market position.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Global market for mice model was valued at more than USD 9.5 billion in 2022 and will progress at over 6% CAGR between 2023 and 2032 propelled by rising demand for humanized mice models.
The inbred segment is poised to reach over USD 4.5 million by 2032 as a result of the growing adoption of inbred mice for studying the genetic bases of phenotypic variation.
CRISPR segment will register over USD 6 billion by 2032 owing to its cost-effectiveness, time efficiency, and convenience compared to traditional gene editing techniques.
North America accounted for over 80% of the mice model market revenue in 2022, attributed to the high prevalence of chronic diseases including diabetes and viral diseases in the region.